Article

Independent information from PET, CSF and plasma biomarkers of tau pathology in Alzheimer’s disease

2021-04-19

Abstract excerpt

<h4>ABSTRACT</h4> PET, CSF and plasma biomarkers of tau pathology may be differentially associated with Alzheimer’s disease (AD) related demographic, cognitive, genetic and neuroimaging markers. We examined 771 participants with normal cognition, mild cognitive impairment or dementia from BioFINDER-2 (n=400) and ADNI (n=371). All had tau-PET ([ 18 F]RO948 in BioFINDER-2, [ 18 F]flortaucipir in ADNI) and CSF p-t...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: d8abc202-4a2b-510c-808a-869238553bd8
DOI: 10.1101/2021.04.19.440402

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Independent information from PET, CSF and plasma biomarkers of tau pathology in Alzheimer’s diseaseDOI 10.1101/2021.04.19.440402Read

Prediction of future Alzheimer’s disease dementia using plasma phospho-tau combined with other accessible measuresSemantic proximity Read

The Alzheimers Association Global Biomarker Standardization Consortium (GBSC) plasma phospho-tau Round Robin studySemantic proximity Read

A Comprehensive Head-to-Head Comparison of Key Plasma Phosphorylated Tau 217 Biomarker TestsSemantic proximity Read

Plasma p-tau217, p-tau181, and Aβ42 Predicts Amyloid PET Positivity in Cognitively Unimpaired AdultsSemantic proximity Read

Robustness of plasma p-Tau217 diagnostic thresholds for Alzheimer’s disease across various clinical populations and laboratory environmentsSemantic proximity Read

<i>APOE4</i>impact on soluble and insoluble tau pathology is mostly influenced by amyloid-betaSemantic proximity Read

Discriminative Accuracy of Plasma Phospho-tau217 for Alzheimer Disease vs Other Neurodegenerative Disorders.Semantic proximity Read

Disentangling relationships between Alzheimer's disease plasma biomarkers and established biomarkers in patients of tertiary memory clinicsSemantic proximity Read

Don't forget about tau: the effects of ApoE4 genotype on Alzheimer's disease cerebrospinal fluid biomarkers in subjects with mild cognitive impairment-data from the Dementia Competence Network.Semantic proximity Read

Clinical and demographic factors modify the association between plasma phosphorylated tau-181 and cognitionSemantic proximity Read

Progress regarding the context-of-use of tau as biomarker of Alzheimer’s disease and other neurodegenerative diseasesSemantic proximity Read

Comprehensive evaluation of AT(N) imaging biomarkers for predicting cognitionSemantic proximity Read